Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110-04 Phase IIa Trial in Postherpetic Neuralgia
jRCT2031240504Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing ONO-1110 with Placebo (2 arms). Primary endpoint: Change in weekly mean of average pain score from baseline. Started Feb 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2031240504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240504.